|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Eppendorf Group, a major German-based manufacturer of laboratory equipment and associated consumables. |
|---|---|
| Transferring Party | New Brunswick Scientific Co., Inc. (Nasdaq:NBSC), a U.S. based manufacturer products for the growth, detection and storage of microorganisms for medical, biological and chemical applications. |
| Sector | Diagnostics |
| Date | July 11, 2007 |
| Analysis Broadens Eppendorf's line and deepens its market share. NBS has a sales force and will benefit from Eppendorf's global distribution network to accelerate the long- term growth of the combined product range. Deal value - $110m, on sales of $73.5 (1.5x) and EBITDA of $6.9m (15.9x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |